A state-wide population-based program for detection of lynch syndrome based upon immunohistochemical and molecular testing of colorectal tumours Lyn SchofieldFabienne GrieuBarry Iacopetta Short Communication 26 November 2011 Pages: 1 - 6
The liver: another organ involved in Muir Torre syndrome? F. MorandoM. AlaibacP. Angeli OriginalPaper 26 May 2011 Pages: 7 - 12
Two novel mutations in hMLH1 gene in Iranian hereditary non-polyposis colorectal cancer patients Somayeh ShahmoradiAli BidmeshkipourMansoor Salehi OriginalPaper 07 September 2011 Pages: 13 - 17
Mutation and association analyses of the candidate genes ESR1, ESR2, MAX, PCNA, and KAT2A in patients with unexplained MSH2-deficient tumors Nils RahnerFelix F. BrockschmidtPeter Propping Original Article 16 November 2011 Pages: 19 - 26
Self-reported mammography use following BRCA1/2 genetic testing may be overestimated Geneviève LaroucheKarine BouchardMichel Dorval Short Communication 13 November 2011 Pages: 27 - 32
Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer Anne Kinhult StåhlbomHemming JohanssonBrita Arver Original Article Open access 29 November 2011 Pages: 33 - 40
Contribution of germline mutations in the BRCA and PALB2 genes to pancreatic cancer in Italy P. GhiorzoV. Pensottifor the Genoa Pancreatic Cancer Study Group Original Article 12 October 2011 Pages: 41 - 47
Low prevalence of BRCA1 and BRCA2 mutations in the sporadic breast cancer of Spanish population Inmaculada de Juan JiménezEva Esteban CardeñosaPascual Bolufer Gilabert Original Article 15 September 2011 Pages: 49 - 56
BRCA1 and BRCA2 germline mutations in 85 Iranian breast cancer patients Fatemeh KeshavarziGholam Reza JavadiSirous Zeinali Original Article 15 September 2011 Pages: 57 - 67
Non-cancer endpoints in BRCA1/2 carriers after risk-reducing salpingo-oophorectomy J. V. CohenL. ChielS. M. Domchek OriginalPaper 06 September 2011 Pages: 69 - 75
Uptake of a randomized breast cancer prevention trial comparing letrozole to placebo in BRCA1/2 mutations carriers: the LIBER trial Pascal PujolChristine LassetOn behalf the French Federation of Cancer Centres (FNCLCC) Original Article 11 November 2011 Pages: 77 - 84
A pre-visit tailored website enhances counselees’ realistic expectations and knowledge and fulfils information needs for breast cancer genetic counselling Akke AlbadaSandra van DulmenMargreet G. E. M. Ausems OriginalPaper 07 September 2011 Pages: 85 - 95
Patient outcomes associated with group and individual genetic counseling formats Erin RothwellWendy KohlmannAnita Kinney Original Article 05 November 2011 Pages: 97 - 106
Implications for cancer genetics practice of pro-actively assessing family history in a General Practice cohort in North West London Kelly KohutLucia D’MelloMichelle Ferris Original Article 21 October 2011 Pages: 107 - 113
Familial renal cancer as an indicator of hereditary leiomyomatosis and renal cell cancer syndrome Victoria M. RaymondCasey M. HerronStephen B. Gruber Original Article 30 November 2011 Pages: 115 - 121
Hereditary leiomyomatosis and renal cell cancer presenting as metastatic kidney cancer at 18 years of age: implications for surveillance Karin Y. van Spaendonck-ZwartsSadhanna BadeloeFred H. Menko Original Article Open access 16 November 2011 Pages: 123 - 129
Case report: a p.C618S RET proto-oncogene germline mutation in a large Chinese pedigree with familial medullary thyroid carcinoma X.-P. QiR.-B. YingX.-N. Zhang Original Article 09 November 2011 Pages: 131 - 136
First degree relatives and familial aggregation of gastric cancer: who to choose for control in case–control studies? Ricardo Marcos-PintoMário Dinis-RibeiroJorge Areias Original Article 05 November 2011 Pages: 137 - 143
Increased incidence of childhood, prostate and breast cancers in relatives of childhood cancer patients Susanne MagnussonThomas WiebeHåkan Olsson Original Article 26 November 2011 Pages: 145 - 155